Delivery Order SPE2DR25D6044-SPE2DR26FYA8L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NESACAINE-MPF 3% Vial 20ML with a ceiling value of $1,424.95 under a firm fixed price contract type. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement...
- This is a $1,514.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NESACAINE-MPF 3% VIAL 20ML, a local anesthetic medication. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a $5,475 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Nesacaine-MPF 3% vials (20 mL) under a firm fixed-price contract structure. The award is non-competitive with no set-aside designation and is scheduled for completion by January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., which is a major pharmaceutical distributor...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of NESACAINE-MPF 3% VIAL 20ML, a pharmaceutical product, to support military treatment programs and facilities. The contract has a ceiling value of $1,923.31 and a period of performance through March 20, 2024. It is a firm fixed price contract, with no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,953.83 to AmerisourceBergen Drug Corp on December 18, 2025, for pharmaceutical products under the contract designation 4570317534. This firm fixed-price delivery order, with an ultimate completion date of January 16, 2026, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xylocaine-MPF 1% Vial 5ML, a local anesthetic medication commonly used in medical and surgical applications. This firm fixed-price delivery order, valued at $2,413.46, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,749.70 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This contract, effective December 31, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $11,025.76 to AmerisourceBergen Drug Corp on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- This delivery order, valued at $1,893.12, was awarded on January 20, 2026, to AmerisourceBergen Drug Corp (a subsidiary of parent company Cencora, Inc.) by the Defense Logistics Agency Medical Supply Chain. The contract is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. This delivery order represents a task order under...
- The Defense Logistics Agency awarded a delivery order valued at $22,129.36 to AmerisourceBergen Drug Corp for pharmaceutical products and supplies. This firm fixed-price delivery order, issued on November 26, 2025, with an ultimate completion date of the same date, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made through competitive procedures with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken,...
- SPE2DR25D6044Indefinite Delivery Contract
- SPE2DR25D6044-SPE2DR26FYA8LDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,537.89 to AmerisourceBergen Drug Corp for NESACAINE-MPF 3% Vial 20ML, a local anesthetic pharmaceutical product. This non-set-aside, competitively awarded contract was issued on January 22, 2026, with an ultimate completion date of January 23, 2026, and is structured as a firm fixed-price delivery order. The awardee, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, where the performance location is also situated. The company operates as a subsidiary of Cencora, Inc., a major pharmaceutical distribution and healthcare solutions provider serving federal agencies. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 indefinite delivery vehicle valued through December 2026. This prime IDC enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs globally, including delivery to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's extensive portfolio of federal medical procurement contracts demonstrates its critical role as a primary pharmaceutical vendor for military and veteran healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/21/26 |